Spots Global Cancer Trial Database for rc48+tislelizumab+carboplatin
Every month we try and update this database with for rc48+tislelizumab+carboplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations | NCT05847764 | Non Small Cell ... ERBB2 Mutation-... RC48 Disitamab Vedot... | RC48+Tislelizum... RC48+Furmonerti... RC48+Furmonerti... | 18 Years - | Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
